|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 266.50 USD | +0.08% |
|
-2.48% | +4.05% |
| Capitalization | 32.05B 27.26B 25.27B 23.61B 44.02B 2,945B 46.66B 289B 115B 1,390B 120B 118B 5,058B | P/E ratio 2025 * |
21.3x | P/E ratio 2026 * | 22.9x |
|---|---|---|---|---|---|
| Enterprise value | 39.85B 33.89B 31.41B 29.35B 54.72B 3,661B 58B 359B 143B 1,728B 149B 146B 6,287B | EV / Sales 2025 * |
0.31x | EV / Sales 2026 * | 0.27x |
| Free-Float |
60.46% | Yield 2025 * |
1.37% | Yield 2026 * | 1.49% |
Last Transcript: Humana Inc.
| 1 day | +0.08% | ||
| 1 week | -2.48% | ||
| Current month | +4.05% | ||
| 1 month | +3.65% | ||
| 3 months | -8.51% | ||
| 6 months | +12.39% | ||
| Current year | +4.05% |
| 1 week | 264 |  | 279.58 |
| 1 month | 254.38 | | 285.6 |
| Current year | 256.04 | | 285.6 |
| 1 year | 206.87 | | 315.35 |
| 3 years | 206.87 | | 541.21 |
| 5 years | 206.87 | | 571.3 |
| 10 years | 150 | | 571.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Rechtin
CEO | Chief Executive Officer | 55 | 01/07/2024 |
Celeste Brown
DFI | Director of Finance/CFO | 49 | 11/01/2025 |
Japan Mehta
CTO | Chief Tech/Sci/R&D Officer | 45 | 01/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kurt Hilzinger
CHM | Chairman | 65 | 01/01/2014 |
Frank D'Amelio
BRD | Director/Board Member | 68 | 01/09/2003 |
Karen Katz
BRD | Director/Board Member | 69 | 23/09/2019 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | 0.00% | 2.3% | 4 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.08% | -2.48% | -9.29% | -46.11% | 32.05B | |
| +0.50% | +7.62% | -32.75% | -26.67% | 323B | |
| -0.32% | -1.02% | -7.55% | -22.36% | 82.46B | |
| -0.42% | +2.57% | -5.35% | -9.40% | 74.58B | |
| +1.48% | +0.74% | -29.22% | -39.19% | 22.65B | |
| +1.58% | +5.48% | -34.10% | -32.09% | 10.38B | |
| +0.85% | +5.82% | +63.42% | +94.05% | 4.76B | |
| +0.88% | +2.85% | +14.53% | -24.78% | 2.17B | |
| Average | +0.44% | +1.25% | -5.04% | -13.32% | 68.97B | |
| Weighted average by Cap. | -0.36% | +3.84% | -22.78% | -24.39% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 129B 110B 102B 95.2B 177B 11,873B 188B 1,164B 462B 5,606B 485B 475B 20,391B | 145B 124B 115B 107B 200B 13,354B 212B 1,309B 520B 6,305B 545B 534B 22,935B |
| Net income | 1.51B 1.28B 1.19B 1.11B 2.07B 139B 2.2B 13.59B 5.4B 65.45B 5.66B 5.54B 238B | 1.42B 1.21B 1.12B 1.05B 1.95B 130B 2.07B 12.79B 5.08B 61.58B 5.32B 5.21B 224B |
| Net Debt | 7.79B 6.63B 6.14B 5.74B 10.7B 716B 11.34B 70.2B 27.87B 338B 29.22B 28.62B 1,230B | 7.78B 6.62B 6.13B 5.73B 10.69B 715B 11.33B 70.11B 27.84B 338B 29.18B 28.58B 1,228B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 266.50 $ | +0.08% | 1,268,557 |
| 22/01/26 | 266.29 $ | -1.62% | 1,096,065 |
| 21/01/26 | 270.67 $ | +1.00% | 1,255,490 |
| 20/01/26 | 268.00 $ | -1.93% | 1,537,272 |
| 16/01/26 | 273.28 $ | -3.76% | 885,654 |
Delayed Quote Nyse, 24 January 2026 at 08:00 am AEDT
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HUM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition